CG Policy · 2024
In this section7 topics
Corporate Governance Policy
Has a Corporate Governance Policy
Yes
Policy Description
The Company places importance on conducting business with integrity, transparency, and responsibility towards society and all stakeholders according to the corporate governance code. Therefore, the Company has established the business code of conduct and the corporate governance code in writing by compiling rules, regulations, criteria, and practices of The Securities and Exchange Commission, Thailand and adapting them to the Company’s practices. The Company has also reviewed them to ensure that they are in line with the changes in legal requirements and specific characteristics of the industry's business operations.
The Company has published its policies and handbooks regarding business ethics as well as the good corporate governance to create understanding. They are also used as guidelines for proper operation of employees at all levels and to provide information to shareholders, stakeholders, investors, and other interested parties in order to determine and disclose the guidelines for promoting compliance with business code of conduct. More details on handbooks regarding business code of conduct and the good corporate governance code are available on the Company's website (www.bangkokchainhospital.com.)
The Board of Directors, which represents the shareholders, is responsible for supervising the business in accordance with the laws, objectives, regulations, and resolutions of the shareholder meeting, as well as overseeing the management to achieve operational goals according to strategies and annual plans approved by the Board of Directors. In order to enhance its operational efficiency, the Board of Directors has therefore appointed subcommittees, namely Audit Committee, Executive Committee, Sustainability, Governance and Risk Management Committee, and Nomination and Remuneration Committee with expertise and experiences in related fields to perform their duties according to the established approval authority with integrity and maintain the Company's interest. More details are available in (56-1 One Report) on the Scope of Power of the Committee section.
As of December 31, 2024 The Company’s Board of Directors had 12 directors, comprising of:
- 7 executive directors, accounted for 58.33% of total directors
- 5 non-executive directors, accounted for 41.67% of total directors
- 3 female directors, accounted for 25.00% of total directors
- 4 independent directors, accounted for 33.33% of total directors
This meets the requirements of The Securities and Exchange Commission, and The Stock Exchange of Thailand. In addition, the Board of Directors has appointed subcommittees as follows:
1) Audit Committee comprises of 3 independent directors whose term of office is equal to that of directors. (Audit Committee members are listed in the Information about Committee section.)
2) Executive Committee comprises of 8 directors and executives (Executive Committee members are listed in the Information about Committee section.) to perform specific duties and propose matters to the Board of Directors for consideration and acknowledgement.
3) Sustainability, Governance and Risk Management Committee comprises of 9 directors and executives. (Sustainability Committee members are listed in the Information about Committee section.)
4) Nomination and Remuneration Committee comprises of 3 directors. (Nomination Committee members are listed in the Information about Committee section.)
Each subcommittee has rights and duties as specified in its regulations. The Company has clearly separated roles and responsibilities between the Board of Directors and senior executives. The Company's Board of Directors is responsible for determining policies and supervising the operations of senior executives at policy level. Senior executives are responsible for managing the Company's operations in various areas in accordance with the established policies. This is to ensure that none of them has absolute unlimited power.
Policy & Practices — Board of Directors
Has Policy & Guidelines for the Board
Yes
Board Guidelines
| Guideline | Other — Please Specify | Detail | Document Link |
|---|---|---|---|
| Nomination of Directors | For the selection of company directors, the Board of Directors collectively reviews and selects individuals to serve as directors, taking into consideration the board diversity, necessary skills and experiences of directors, qualifications and expertise beneficial to the company or a Board Skills Matrix. The suitability is assessed based on qualifications, experiences, expertise, and past performance as company directors. Additionally, there is no gender bias to enhance diversity in the recruitment of qualified individuals as directors who shall have no prohibited characteristics according to laws and the Notification of the Securities and Exchange Commission, Thailand. Furthermore, the Board of Directors meeting No. 2/2023 on February 28, 2023 appointed the Nomination and Remuneration Committee to support the recruitment and selection of directors with qualifications suitable for the Company's business strategies, as well as evaluating performance and considering appropriate remuneration.
The procedures of appointing the Board of Directors are as follows: 1. One shareholder holds one vote per share. 2. Shareholders shall cast their votes to individually elect directors. 3. Individuals who receive the highest number of votes in descending order are elected as directors, up to the designated number of directors. In the event that the number of individuals with tie votes exceeds the designated number of directors, the Chairman shall cast the deciding vote. | https://www.bangkokchainhospital.com/en/governance/cg-policies-and-compliance | |
| Determination of Director Remuneration | The Company has established a clear and transparent remuneration policy for directors, which has been approved by shareholders. The remuneration for executives is determined with the consideration of remuneration data of companies in the same industry in similar size, the Company's turnover and each executive’s performance. Furthermore, the Board of Directors meeting No. 2/2023 on February 28, 2023 appointed the Nomination and Remuneration Committee to support the recruitment and selection of directors with qualifications suitable for the Company's business strategies, as well as evaluating performance and considering appropriate remuneration for directors. | https://www.bangkokchainhospital.com/en/governance/cg-policies-and-compliance | |
| Independence of the Board of Directors from the Management | The Company's Board of Directors consists of people with knowledge and capabilities in various fields who play an essential role in determining the Company's policies in collaboration with senior executives, planning both short-term and long-term operations, as well as setting financial policies and risk management and the organization overview. They also have a pivotal role in supervising, inspecting and evaluating the Company's and senior executives’ performances to ensure that they align with the plans. | https://www.bangkokchainhospital.com/en/governance/cg-policies-and-compliance | |
| Director Development | The Company's Board of Directors has a policy to promote and facilitate trainings and knowledge enhancement for its directors and executives to continuously improve and perform duties effectively through both internal and external training programs. Each member of the Board of Directors is required to undergo trainings to understand their roles as directors, committee members, and senior executives. The Board of Directors has participated in training courses provided by the Thai Institute of Directors (IOD), including the Director Certification Program (DCP) and the Director Accreditation Program (DAP).
For the orientation of new directors, the Board of Directors assigns the Company Secretary to prepare various information for the new directors. This is to ensure that the new directors are briefed on their roles, duties, responsibilities, the Company's policies, business information, and corporate governance practices before they assume their duties. This initiative aims to promote knowledge and understanding of the business for all directors, supporting them in performing their duties efficiently. Additionally, the Company has a policy to consistently enhance the knowledge of both directors and executives. | https://www.bangkokchainhospital.com/en/governance/cg-policies-and-compliance | |
| Board Performance Evaluation |
The Company has conducted monitoring to ensure strict compliance with the corporate governance code and corporate ethics. This monitoring, with a particular emphasis on matters related to disclosure of information, related party transactions, acquisition or disposal of assets, investments in and oversight of subsidiaries, and risk management, has revealed that the Company has adhered comprehensively to the relevant policies and practices. Performance Appraisal of the Board of Directors and Subcommittees The Company has stipulated the regular annual assessment of the Board of Directors and subcommittees. The assessment is conducted in 3 formats: 1. Self-assessment form of each committee The self-assessment form of each committee has adopted guidelines from the Stock Exchange of Thailand to suit the characteristics and structure of the committee. The assessment results will play a crucial role in enhancing the performance and effectiveness of the committee's duties and operations. The committee evaluates the level of opinion scores or the level of implementation in 4 main topics: 1) Structure and qualifications of the board/committee 2) The board/committee meetings 3) Roles, duties, and responsibilities of the board/committee members 4) Other aspects such as the relationship between the committee and the management division The Company Secretary distributes the self-assessment forms to all board/committee members for their self-evaluation at the end of each year. The secretary is responsible for collecting and summarizing the results, presenting them at the Board of Directors meetings for consideration, acknowledgment, and discussion on an annual basis. 2. Self-assessment form of each board/committee member The self-assessment form for individual board/committee members serves as a tool to facilitate the review and development of their performance, ensuring effectiveness. The assessment categories align with the key responsibilities of board/committee members as stipulated by laws, charters, ethics, best practices of the Securities and Exchange Commission, and the Stock Exchange of Thailand. These categories include: 1) Structure and qualifications of the board/committee 2) The board/committee meetings 3) Roles, duties, and responsibilities of the Board of Directors and subcommittees The Company Secretary distributes the self-assessment forms to all board/committee members for their self-evaluation at the end of each year. The secretary is responsible for collecting and summarizing the results, presenting them at the Board of Directors meetings for consideration, acknowledgment, and discussion on an annual basis. 3. Performance assessment of the Chief Executive Officer The performance assessment of the of the Chief Executive Officer is divided into 2 categories, following the assessment guidelines set by the Stock Exchange of Thailand. These categories include: Category 1 Performance assessment, consisting of 11 evaluation criteria as follows: 1. Leadership 2. Strategy formulation 3. Strategy implementation 4. Financial planning and performance 5. Operations in environmental, social, and corporate governance aspects 6. Relationship with the Board 7. Relationship with external parties 8. Operations management and employee relations 9. Succession planning 10. Knowledge in products and services 11. Personal qualifications Category 2 Development of the Chief Executive Officer, consisting of strengths and areas of improvement. The Board of Directors provides additional insights in this category. The Chief Executive Officer has participated in setting his or her own performance goals and acknowledges the approved goals each year. Subsequently, at the end of each year, the Company Secretary distributes the assessment forms to all board/committee members to assess the Chief Executive Officer. The Chief Executive Officer also conducts a self-assessment, which is used for a comparison of results and as valuable information for future development.
In addition, the Company Secretary shall compile and report the results at the Board of Directors meeting for consideration, acknowledgment and discussion on an annual basis. | ||
| Corporate Governance of Subsidiaries and Associated Companies | The Company has considered appointing directors and executives as directors of each subsidiary, with the approval of the Board. In the event that these directors and executives no longer hold positions in the subsidiary, the Board of Directors will consider appointing individuals to oversee the interests from time to time. The Company has also established policies for significant transactions, such as related party transactions. | ||
| Other guidelines regarding the board of directors | Roles, Duties, and Responsibilities of the Board of Directors | The Company's Board of Directors engages in establishing the Company's visions, missions, strategies, goals, business plans, and budgets. Additionally, they oversee the management to ensure efficient and effective implementation of business plans, as well as establishing internal control systems, internal audits, and appropriate risk management measures. These operations have been regularly monitored in the Board of Director meetings. Moreover, scope of powers of the Board of Directors, Audit Committee, Executive Committee, Sustainability, Governance and Risk Management Committee, Nomination and Remuneration committee, as well as the Chief Executive Officer has been clearly and transparently determined. The Company has established regulations and guidelines of business code of conduct in writing, as well as penal provisions. This is intended to guide stakeholders in carrying out their duties in line with the Company's missions with integrity. The Company has policies and procedures for addressing ethical issues, ensuring compliance with laws, moral standards, and societal customs. Furthermore, the Company upholds ethical practices concerning service charges and service recipients have the right to request details and expense for medical treatments. The Company adheres to the Health Facility Act B.E. 2541 (1998) and also complies with ethical standards in public relations, adhering to the Private Health Facility Act. The Company has a clear management structure and measures to prevent conflicts of interest. For example, in case the Company deems that conflicts of interest may arise from any directors, such director shall abstain from voting. The Company has appointed the Audit Committee to share opinions and review the validity of related transactions to present to the Board of Directors. In addition, the Company has disclosed related transactions in the financial statements in accordance with established financial reporting standards. | |
| Other guidelines regarding the board of directors | Board of Directors Meeting | The Board of Directors determines at least 4 meetings per year with additional extraordinary meetings held as necessary. Clear agendas are set in advance with regular performance monitoring agenda. The Company sends invitation letters along with the agendas and documents at least 7 days prior to the meeting to provide directors sufficient time to review the information before attending the meeting. In each meeting, the Chairman provides an opportunity for each director to express their opinions independently. In cases where any director has a vested interest in the matter under consideration, he or she is required to inform the meeting, refrain from expressing opinions, and abstain from voting on that specific matter. The minimum quorum required for decision-making at a board meeting is at least two-thirds of the entire board. | |
| Other guidelines regarding the board of directors | Internal Control and Audit System | The Company places importance on effective internal control system at both the management and operational levels. Clear responsibilities and authorities for employees and executives have been defined. There are controls in place to oversee asset usage and duties are segregated among employees, control monitors, and evaluators to ensure appropriate checks and balances. Additionally, the Company has an internal control system related to financial operations, including a financial reporting system that presents reports to the executives in charge. The Company has appointed internal auditors from Dharmniti Internal Audit Co., Ltd., an independent internal audit firm, with appropriate qualifications to serve as the Company’s internal auditors. The selection is based on the adequacy of personnel, experience, knowledge, skills, and independence of the internal auditors to perform the duties of auditing various parts of the Company's operations. This is in accordance with the specified evaluation criteria for the adequacy of the internal control system. The internal audit department is responsible for examining the operations of all units, conducting regular audits based on the annual audit plan, including the inspection of bookkeeping, bank deposit transactions, as well as conducting physical counts of inventory and fixed assets. In case of suspicion or any abnormal incidents within any unit, the internal audit department promptly investigates the operations of that unit the truth is ascertained. Then, the internal audit department regularly compiles audit reports and informs the Audit Committee of their findings. |
Code of Conduct
Has a Business Code of Conduct
Yes
Code of Conduct Description
The Company's Board of Directors is committed to conducting business with integrity and fairness by establishing the Business Code of Conduct in writing. The code of conduct is intended to be used and disseminated to all directors, executives, and employees to ensure understanding of the ethical standards the Company adheres to in its business operations. It also serves as a guideline to demonstrate the Company's intention of transparent and responsible business practices with consideration of stakeholders, society, and environment. The aforementioned code of conduct reflects the Company's values and guidelines for employees' behavior and work practices within established ethical frameworks.
Code of Conduct Practices
| Guideline | Other — Please Specify | Detail | Document Link |
|---|---|---|---|
| Prevention of Misuse of Inside Information | The Company has established a policy regarding the Board of Directors, executives, and employees, requiring them to fulfill their duties for the utmost benefit of the Company. In cases where any individual has a vested interest or involvement in a matter under consideration, such individuals must notify the Internal Audit Unit responsible for such matters and refrain from participating in the deliberation of the relevant transaction. The Company has established measures to prevent conflicts of interest that may arise from related party transactions of the Company and individuals with possible conflicts. Individuals with vested interests in any matter are not allowed to participate in the approval of such transactions. The Board of Directors ensures compliance with securities and exchange laws and regulations, notifications, orders, or provisions of the Stock Exchange of Thailand. This includes adherence to disclosure requirements for related party transactions and the acquisition or disposal of significant assets of the Company. The Company also adheres strictly to accounting standards set by the accountant association. Furthermore, the Company arranges with the Audit Committee, auditors, or independent experts, as appropriate, to inspect and provide opinions on the reasonableness of related party transactions. The details of such related party transactions will be disclosed in the notes to financial statements which have inspected or reviewed by the auditors. The details are available in the corporate governance section under the internal control and related party transactions section. | ||
| Anti-corruption | The Company has established policies and processes to anti-corruption, with a committee overseeing internal control systems. The executives are responsible for creating awareness and communicating these policies to employees. The Company has disclosed details of its anti-corruption policies on its website (www.bangkokchainhospital.com) in the Investor Relations section, under the good corporate governance. - The Company declared its commitment to participate in the Thai Private Sector Collective Action Against Corruption (CAC) on November 10, 2017 and has consistently renewed its participation. In this regard, the Company has implemented measures in line with its anti-corruption policies. - The Company has established a regular risk assessment to identify potential risks arising from corruption and consistently reviewed the risk management measures to ensure that they remain appropriated and at the admissible level which can be referenced from the corruption risk management guidelines. - The Company and its subsidiaries conduct initial orientation training for new employees and provide ongoing knowledge development trainings for the Board, executives, and employees to ensure that everyone has a clear understanding of the anti-corruption measures, the Company's expectations, and the penal provision. - Directors, executives, and employees will receive a copy of policies in a brochure format, and complete policies can be obtained from the Company's website. Additionally, the Company will communicate through annual events to ensure that everyone is informed and understands the Company's policies against corruption. - The Company will conduct regular reviews of the anti-corruption policies, at least once a year. The Risk Management Committee will present them to the Audit Committee for consideration regarding adequacy and effectiveness. This includes reporting on the results of risk assessments and providing recommendations to the Board of Directors concerning best practices that shall be maintained. - The internal control systems and various regulations will undergo periodic reviews by the Internal Audit Department. Issues discovered during these reviews shall be promptly reported to the Audit Committee to ensure that the internal control systems are effective and sufficient for combating corruption. - The Company encourages business partners to participate in the anti-corruption initiative. | https://www.bangkokchainhospital.com/storage/document/cg/bch-anti-corruption-brochure-th.pdf | |
| Whistleblowing and Protection of Whistleblowers | The Company has established a mechanism for receiving and addressing complaints, particularly those regarding violation of laws, regulations, and ethics or behaviors that may suggest corruption by company personnel. This includes protective measures appropriate for whistleblowers, as outlined in the complaint handling policy on corruption. Reports or whistleblowing can be done through the following channels: Tel : 02-836-9937 Fax : 02-106-4858 Email : report@bangkokchainhospital.com Website : www.bangkokchainhospital.com Postal : Addressed to “Complaint Handler” Bangkok Chain Hospital Public Company Limited World Medical Hospital building, 22nd floor 44 Moo 4, Chaengwattana Road, Pakkred Subdistrict, Pakkred District, Nonthaburi Province 11120 Note: The "Complaint Handler" refers to the Company Secretary. | https://www.bangkokchainhospital.com/storage/document/cg/bch-whistleblowing-and-complaint-policy-th.pdf | |
| Preventing the Misuse of Inside Information | The Company has a policy prohibiting its directors and executives from using material internal information that has not been disclosed to the public for personal gain, including the buying or selling of company securities. Directors, executives, and employees with access to internal information should refrain from or abstain from trading company securities during the one-month period prior to the public disclosure of financial statements. The Company has informed executives of various departments about their responsibilities in holding securities of the Company, as well as those of their spouses and underage children. Additionally, they are required to report changes in their securities holdings to the Securities and Exchange Commission in accordance with section 59 and the penalty clause outlined in section 22 of the Securities and Exchange Act (No. 5) B.E. 2559 (2016) In 2023, there were no instances of directors, executives, and employees committing offenses related to the misuse of internal information and securities trading during the blackout period. The Company has also established penalties for cases of non-compliance by using the Company's internal information for personal gain, ranging from verbal warnings to termination of employment. | https://www.bangkokchainhospital.com/storage/document/cg/bch-securities-trading-policy-th.pdf | |
| Other guidelines related to business code of conduct | Disclosure and Transparency | The Company has information disclosure policy regarding the operations and performance of the company which shall be disclosed in an accurate, complete, consistent, timely, transparent, and reliable manner. Shareholder structure shall be presented clearly to show ultimate shareholders. Details on shareholding structure as well as the corporate governance are available in the annual information disclosure form (56-1 One Report). The Company has clearly and transparently established a policy, which had been approved by shareholders, on remuneration for directors. In this regard, the remuneration of the Company's executives is determined with the consideration of remuneration data of companies in the same industry in similar size, the Company's turnover and each executive’s performance. The Board of Directors is responsible for the consolidated financial statements of the Company and its subsidiaries, as well as the financial information in the annual report. The financial statements are provided in accordance with financial reporting standards by selecting and adhering to appropriate accounting policies with caution and best estimation. Important information shall be sufficiently disclosed in the remarks on financial statements. The Company has appointed the Audit Committee which consists of independent non-executive directors who are responsible for the quality of the Company's financial reports and internal control system. The Company has policies to have investor relations mangers responsible for complete, accurate, truthful, reliable disclosure of information in a timely and transparent manner, as well as equally and fairly communicating with third parties, such as shareholders, qualified institutional buyers, general investors, analysts, and related departments. The Company provides information regarding the Company and its performances, financial statements, and information reported to the Stock Exchange of Thailand. More details are available on the Stock Exchange of Thailand’s website at www.set.or.th and the Company’s website at www.bangkokchainhospital.com. In cases where investors and related parties have questions or inquiries for additional information, please contact the Finance Director in charge of Investor Relations via email ir@bangkokchainhospital.com or via the Company’s website at www.bangkok chainhospital.com or call 02-836-9940 Whistleblowing Stakeholders may file a complaint regarding operations which violate the laws, a breach of or non-compliance with the Company’s regulations via the following channels: Email : report@bangkokchainhospital.com Postal : Addressed to Complaint Handler, Bangkok Chain Hospital Public Company Limited, World Medical Hospital, 22nd Floor 44 Moo 4, Chaengwattana Road, Pakkred Subdistrict, Pakkred District, Nonthaburi Province 11120 | https://www.bangkokchainhospital.com/storage/document/cg/bch-information-disclosure-policy-th.pdf |
Promoting Compliance with the Code of Conduct
Promotes Compliance by Directors, Executives and Employees
Yes
Description
The Company conducts announcements, training sessions, and internal communications in various forms to ensure that everyone is aware of and strictly adheres to the ethical frameworks. This has been closely monitored by the Board of Directors to ensure strict compliance with these codes of conduct.
Anti-Corruption Networks & Projects
Joined or Declared Intent to Join Anti-Corruption Networks
Yes
Networks & Projects Joined
| Network / Project | CAC Certified |
|---|---|
| Thai Private Sector Collective Action Against Corruption: CAC | Y |
| United Nations Global Compact (UNGC) | |
| Participation of anti-Corruption networks and initiatives |
Material Changes & Developments in CG
Reviewed the CG Policy or Board Charter in the Past Year
Yes
Material Changes or Developments in the Past Year
Yes
Policy Review — Description
The Company adheres to and follows the principles of good corporate governance in its operations through the Board of Directors, executives, and employees and considers good corporate governance principles as a crucial factor in promoting its overall success as a socially responsible organization. The Board of Directors meeting No. 1/2025 on January 13, 2025 reviewed its policies and guidelines on corporate governance in accordance with the guidelines announced by The Securities and Exchange Commission, Thailand (SEC) or Principles of Good Corporate Governance for Listed Companies 2017 (CG Code). This serves as a framework for the Board of Directors and the listed companies to apply in their corporate governance practices for good turnover in a long run. Additionally, the Board of Directors has reviewed policies, guidelines, and charters of all committees to ensure alignment with current business operations and situations.
In 2024, the Company underwent developments and improvements in its policies and corporate governance as follows:
Implements the CG Code for Listed Companies
Yes
CG Code — Description
Bangkok Chain Hospital Public Company Limited has adopted the principles of good corporate governance (CG Code) for listed companies as prescribed by the Securities and Exchange Commission (SEC). The company emphasizes transparency, accountability, and comprehensive disclosure through the following approaches:
Enhancing and Strengthening the Board Structure
The company has established a clear structure for the Board of Directors and the Audit Committee, with well-defined roles and responsibilities. Emphasis is placed on including independent members separate from key executives to ensure fair and effective decision-making.
Integrating ESG Principles and International Standards
In applying the CG Code, the company has incorporated environmental, social, and governance (ESG) principles into its management policies. Clear goals and key performance indicators (KPIs) are set to monitor progress and assess management effectiveness in all aspects.
Disclosure and Reporting Guidelines
The company prioritizes continuous and transparent disclosure of corporate governance-related information. Reports on management performance, risk management, and internal audits are regularly published to provide investors and stakeholders with essential and beneficial information for decision-making.
Utilizing Technology and Innovation in Governance Processes
To enhance management and auditing efficiency, the company employs information technology for data collection, analysis, and disclosure. The use of automation and IT systems reduces complexity in decision-making and internal auditing processes.
Performance Evaluation and Monitoring
A systematic evaluation process is in place to assess the performance of the Board of Directors and executives regularly. The assessment results are used to refine management strategies, ensuring alignment with the CG Code set by the SEC.
Bangkok Chain Hospital Public Company Limited has integrated the CG Code into its policies, reinforcing investor confidence and strengthening long-term stakeholder trust.
Other CG Performance & Outcomes
The company is committed to continuously reviewing and improving its policies and practices in accordance with good corporate governance principles. This ensures that the company’s policies align with the corporate governance standards for listed companies. In 2024, the company underwent corporate governance performance evaluations and received the following recognitions:
• SET ESG Ratings: The company received an "AA" rating from the Stock Exchange of Thailand for the second consecutive year. This reflects its commitment to sustainable business practices that consider environmental, social, and governance (ESG) factors while maintaining strong financial performance and long-term value creation for shareholders and stakeholders.
• Corporate Governance Recognition: The company was awarded a 5-star "Excellent" rating for corporate governance for the second consecutive year, based on the results of the 2024 Corporate Governance Report (CGR) for listed companies.
• ESG100 Recognition: The company was included in the ESG100 list for 2024, selected from 920 listed securities. It was recognized as an outstanding performer in ESG within the services sector and has been part of the ESG100 list for seven consecutive years (2018-2024).
• Sustainability Disclosure Recognition: The company received a Sustainability Disclosure Recognition from the Thaipat Institute for the second consecutive year.
• Outstanding Investor Relations Award: The company was honored with the Outstanding Investor Relations Award 2024 at the SET Awards 2024, a prestigious recognition in the Thai capital market. This award highlights the company’s dedication to building investor confidence and maintaining strong stakeholder engagement.
• Corporate Excellence Award: The company received the Corporate Excellence Award in the Healthcare, Pharmaceutical & Biotechnology category at the Asia Pacific Enterprise Awards (APEA) 2024 Regional Edition. This award recognizes the company as a leader in healthcare management, demonstrating effective corporate leadership, strong operational performance, and a commitment to environmental, social, and good governance practices.

